199 related articles for article (PubMed ID: 22085697)
1. Subjective, psychomotor, and physiological effects of pregabalin alone and in combination with oxycodone in healthy volunteers.
Zacny JP; Paice JA; Coalson DW
Pharmacol Biochem Behav; 2012 Jan; 100(3):560-5. PubMed ID: 22085697
[TBL] [Abstract][Full Text] [Related]
2. Subjective, psychomotor, and physiological effects of oxycodone alone and in combination with ethanol in healthy volunteers.
Zacny JP; Gutierrez S
Psychopharmacology (Berl); 2011 Dec; 218(3):471-81. PubMed ID: 21603891
[TBL] [Abstract][Full Text] [Related]
3. Within-subject comparison of the psychopharmacological profiles of oral oxycodone and oral morphine in non-drug-abusing volunteers.
Zacny JP; Lichtor SA
Psychopharmacology (Berl); 2008 Jan; 196(1):105-16. PubMed ID: 17899018
[TBL] [Abstract][Full Text] [Related]
4. Effects of the NK1 antagonist, aprepitant, on response to oral and intranasal oxycodone in prescription opioid abusers.
Walsh SL; Heilig M; Nuzzo PA; Henderson P; Lofwall MR
Addict Biol; 2013 Mar; 18(2):332-43. PubMed ID: 22260216
[TBL] [Abstract][Full Text] [Related]
5. Subjective, psychomotor, and physiological effects profile of hydrocodone/acetaminophen and oxycodone/acetaminophen combination products.
Zacny JP; Gutierrez S
Pain Med; 2008; 9(4):433-43. PubMed ID: 18489634
[TBL] [Abstract][Full Text] [Related]
6. Within-subject comparison of the psychopharmacological profiles of oral hydrocodone and oxycodone combination products in non-drug-abusing volunteers.
Zacny JP; Gutierrez S
Drug Alcohol Depend; 2009 Apr; 101(1-2):107-14. PubMed ID: 19118954
[TBL] [Abstract][Full Text] [Related]
7. Characterizing the subjective, psychomotor, and physiological effects of oral oxycodone in non-drug-abusing volunteers.
Zacny JP; Gutierrez S
Psychopharmacology (Berl); 2003 Nov; 170(3):242-254. PubMed ID: 12955305
[TBL] [Abstract][Full Text] [Related]
8. The relative abuse liability of oral oxycodone, hydrocodone and hydromorphone assessed in prescription opioid abusers.
Walsh SL; Nuzzo PA; Lofwall MR; Holtman JR
Drug Alcohol Depend; 2008 Dec; 98(3):191-202. PubMed ID: 18606504
[TBL] [Abstract][Full Text] [Related]
9. A randomized, controlled trial of oxycodone versus placebo in patients with postherpetic neuralgia and painful diabetic neuropathy treated with pregabalin.
Zin CS; Nissen LM; O'Callaghan JP; Duffull SB; Smith MT; Moore BJ
J Pain; 2010 May; 11(5):462-71. PubMed ID: 19962354
[TBL] [Abstract][Full Text] [Related]
10. Profiling the subjective, psychomotor, and physiological effects of a hydrocodone/acetaminophen product in recreational drug users.
Zacny JP; Gutierrez S; Bolbolan SA
Drug Alcohol Depend; 2005 Jun; 78(3):243-52. PubMed ID: 15893155
[TBL] [Abstract][Full Text] [Related]
11. Separate and combined psychopharmacological effects of alprazolam and oxycodone in healthy volunteers.
Zacny JP; Paice JA; Coalson DW
Drug Alcohol Depend; 2012 Aug; 124(3):274-82. PubMed ID: 22365897
[TBL] [Abstract][Full Text] [Related]
12. Human abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone.
Tompkins DA; Lanier RK; Harrison JA; Strain EC; Bigelow GE
Psychopharmacology (Berl); 2010 Jul; 210(4):471-80. PubMed ID: 20386884
[TBL] [Abstract][Full Text] [Related]
13. Intranasal abuse potential of an abuse-deterrent oxycodone formulation compared to oxycodone immediate release and placebo in nondependent, recreational opioid users.
Setnik B; Schoedel K; Bartlett C; Dick C; Hakim N; Geoffroy P
J Opioid Manag; 2017; 13(6):449-464. PubMed ID: 29308591
[TBL] [Abstract][Full Text] [Related]
14. Psychopharmacological effects of oxycodone in volunteers with and without generalized anxiety disorder.
Zacny JP; Gutierrez S; Kirulus K; McCracken SG
Exp Clin Psychopharmacol; 2011 Apr; 19(2):85-94. PubMed ID: 21463065
[TBL] [Abstract][Full Text] [Related]
15. Psychopharmacological effects of oxycodone in healthy volunteers: roles of alcohol-drinking status and sex.
Zacny JP; Drum M
Drug Alcohol Depend; 2010 Mar; 107(2-3):209-14. PubMed ID: 19948383
[TBL] [Abstract][Full Text] [Related]
16. Abuse liability of oxycodone as a function of pain and drug use history.
Comer SD; Sullivan MA; Vosburg SK; Kowalczyk WJ; Houser J
Drug Alcohol Depend; 2010 Jun; 109(1-3):130-8. PubMed ID: 20079977
[TBL] [Abstract][Full Text] [Related]
17. Subjective and psychomotor effects of carisoprodol in combination with oxycodone in healthy volunteers.
Zacny JP; Paice JA; Coalson DW
Drug Alcohol Depend; 2012 Jan; 120(1-3):229-32. PubMed ID: 21840651
[TBL] [Abstract][Full Text] [Related]
18. Abuse potential of intravenous oxycodone/naloxone solution in nondependent recreational drug users.
Colucci SV; Perrino PJ; Shram M; Bartlett C; Wang Y; Harris SC
Clin Drug Investig; 2014 Jun; 34(6):421-9. PubMed ID: 24756361
[TBL] [Abstract][Full Text] [Related]
19. Gabapentin increases the abuse liability of alcohol alone and in combination with oxycodone in participants with co-occurring opioid and alcohol use disorder.
Castillo F; Jones JD; Luba RR; Mogali S; Foltin RW; Evans SM; Comer SD
Pharmacol Biochem Behav; 2022 Nov; 221():173482. PubMed ID: 36244527
[TBL] [Abstract][Full Text] [Related]
20. Intravenous oxycodone, hydrocodone, and morphine in recreational opioid users: abuse potential and relative potencies.
Stoops WW; Hatton KW; Lofwall MR; Nuzzo PA; Walsh SL
Psychopharmacology (Berl); 2010 Oct; 212(2):193-203. PubMed ID: 20665209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
